Synthesis, docking and anti-tumor activity of β-L-1,3-thiazolidine pyrimidine nucleoside analogues

Sriharsha, S. N and Pai, K. S. R. and Suhas and Sheena, S. and Nagasuma Chandra and Prabhu, K. R. (2007) Synthesis, docking and anti-tumor activity of β-L-1,3-thiazolidine pyrimidine nucleoside analogues. Medicinal Chemistry, 3 (5). pp. 425-432. ISSN 1875-6638

Full text not available from this repository. (Request a copy)
Official URL: https://dx.doi.org/ 10.2174/157340607781745500

Abstract

In the search for effective, selective, and nontoxic antiviral and antitumor agents, a variety of strategies have been devised to design nucleoside analogues. Here we have described the versatile synthesis of β-L-1,3- thiazolidine nucleoside analogues. These analogues are all derived from the key stereochemically defined intermediate Ntert- butoxy-carbonyl-4-hydroxymethyl-1,3-thiazolidine-2-ol which was accessible in 57% yield starting from L-Cysteine methylester hydrochloride. N-tert-butoxycarbonyl-2-acyloxy-4-trityloxymethyl-1,3-thiazolidine was coupled with the pyrimidine bases in the presence of Lewis acids stannic chloride or trimethyl silyl triflate following Vorbruggen procedure. Proof of the structure and configuration was obtained through 1H NMR, 13C NMR, Mass, elemental analysis and NOE experiments. Docking and antitumor activity of these nucleoside analogues are also reported.

Item Type: Article
Subjects: C Chemical Science > Chemistry
Divisions: Department of > Chemistry
Depositing User: C Swapna Library Assistant
Date Deposited: 09 Sep 2019 10:20
Last Modified: 09 Sep 2019 10:20
URI: http://eprints.uni-mysore.ac.in/id/eprint/7870

Actions (login required)

View Item View Item